Free Trial

UiPath (NYSE:PATH) Shares Down 3.5% - What's Next?

UiPath logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Shares fell 3.5% to $10.92 on Tuesday (intraday low $10.63) with volume ~37.5M shares—about 29% above average—leaving the stock below its 50‑day ($15.14) and near its 200‑day ($14.00) moving averages.
  • Wall Street maintains a consensus "Hold" on UiPath with an average price target of $15.77, though several firms have recently raised targets (Morgan Stanley $19, Barclays $18, Evercore $17), implying some upside but tempered expectations.
  • UiPath recently beat quarterly estimates (EPS $0.16 vs $0.14; revenue $411.1M vs $392.5M, +15.9% YoY), but insiders sold roughly 950,048 shares (~$15.9M) last quarter; insiders own 23.19% and institutions 62.5% of the stock.
  • Interested in UiPath? Here are five stocks we like better.

UiPath, Inc. (NYSE:PATH - Get Free Report)'s share price dropped 3.5% on Tuesday . The company traded as low as $10.63 and last traded at $10.92. Approximately 37,510,391 shares were traded during trading, an increase of 29% from the average daily volume of 29,063,504 shares. The stock had previously closed at $11.32.

Wall Street Analysts Forecast Growth

PATH has been the subject of several analyst reports. Evercore upped their target price on UiPath from $15.00 to $17.00 and gave the company an "in-line" rating in a research note on Thursday, December 4th. Barclays upped their price objective on shares of UiPath from $16.00 to $18.00 and gave the company an "equal weight" rating in a research note on Monday, January 12th. Morgan Stanley raised their target price on shares of UiPath from $15.00 to $19.00 and gave the stock an "equal weight" rating in a research report on Tuesday, December 9th. Mizuho boosted their target price on shares of UiPath from $14.00 to $15.00 and gave the company a "neutral" rating in a report on Thursday, December 4th. Finally, Truist Financial set a $17.00 price target on shares of UiPath in a research note on Thursday, December 4th. One investment analyst has rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, UiPath presently has a consensus rating of "Hold" and a consensus price target of $15.77.

Read Our Latest Analysis on UiPath

UiPath Stock Performance

The firm has a fifty day moving average of $15.14 and a 200-day moving average of $14.00. The stock has a market capitalization of $5.84 billion, a price-to-earnings ratio of 94.33, a P/E/G ratio of 1.55 and a beta of 1.07.

UiPath (NYSE:PATH - Get Free Report) last issued its earnings results on Wednesday, December 3rd. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.02. The company had revenue of $411.11 million during the quarter, compared to the consensus estimate of $392.46 million. UiPath had a return on equity of 3.73% and a net margin of 14.79%.The company's revenue was up 15.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.11 earnings per share. On average, analysts predict that UiPath, Inc. will post -0.17 EPS for the current year.

Insiders Place Their Bets

In other UiPath news, CFO Ashim Gupta sold 67,468 shares of the company's stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $16.10, for a total value of $1,086,234.80. Following the completion of the transaction, the chief financial officer directly owned 557,028 shares of the company's stock, valued at $8,968,150.80. This represents a 10.80% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $19.21, for a total value of $864,450.00. Following the sale, the chief executive officer directly owned 29,153,585 shares in the company, valued at approximately $560,040,367.85. The trade was a 0.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 950,048 shares of company stock worth $15,881,744 in the last quarter. 23.19% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On UiPath

Several hedge funds and other institutional investors have recently bought and sold shares of the business. D.A. Davidson & CO. raised its stake in UiPath by 23.8% during the third quarter. D.A. Davidson & CO. now owns 752,448 shares of the company's stock worth $10,068,000 after acquiring an additional 144,832 shares during the period. Jackson Creek Investment Advisors LLC bought a new position in shares of UiPath during the third quarter valued at approximately $1,579,000. AlphaQuest LLC raised its position in shares of UiPath by 863.9% during the 2nd quarter. AlphaQuest LLC now owns 42,847 shares of the company's stock worth $548,000 after purchasing an additional 38,402 shares during the period. Russell Investments Group Ltd. raised its position in shares of UiPath by 7.3% during the 2nd quarter. Russell Investments Group Ltd. now owns 1,445,644 shares of the company's stock worth $18,448,000 after purchasing an additional 98,058 shares during the period. Finally, Campbell & CO Investment Adviser LLC lifted its holdings in shares of UiPath by 115.3% in the 3rd quarter. Campbell & CO Investment Adviser LLC now owns 141,752 shares of the company's stock worth $1,897,000 after purchasing an additional 75,927 shares during the last quarter. 62.50% of the stock is currently owned by hedge funds and other institutional investors.

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines